ITC Begins Section 337 Investigation on Dermatological Treatment Devices
The International Trade Commission is beginning a Section 337 investigation on allegations that imported dermatological treatment devices infringe patents held by Serendia, the ITC said in a notice (ITC Inv. No. 337-TA-1356). In a March 1 complaint, Serendia said 15 companies are importing and selling merchandise that copies its patented methods and items for treating skin tissue using bipolar electrodes in portable devices. The ITC will consider whether to issue a limited exclusion order and cease and desist orders against the following respondents to the investigation:
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
- Sung Hwan E&B Co., LTD., d/b/a SHEnB Co. LTD, of Seoul, South Korea
- Aesthetics Biomedical, Inc., of Phoenix, Arizona
- Cartessa Aesthetics, LLC, of Melville, New York
- Lutronic Corporation of Gyeonggi-do, South Korea
- Lutronic Aesthetics, Inc., aka Lutronic Inc., of Billerica, Massachusetts
- Lutronic, LLC, of Billerica, Massachusetts
- Ilooda Co., Ltd., of Gyeonggi-do, South Korea
- Cutera, Inc., of Brisbane, California
- Jeisys Medical Inc. of Seoul, South Korea
- Cynosure, Inc., of Westford, Massachusetts
- Rohrer Aesthetics, LLC, of Homewood, Alabama
- Rohrer Aesthetics, Inc., of Homewood, Alabama
- EndyMed Medical Ltd., of Caesarea, Israel
- EndyMed Medical, Ltd., of New York, New York
- EndyMed Medical Inc., of Freehold, New Jersey.